
JBIO vs NVS
$JBIO vs $NVS head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
JBIO vs NVS: the quick read
- ·NVS is the larger company by market cap ($291.20B vs $900M).
- ·JBIO has been more active on our scanner (80 vs 24 alerts in 30 days).
- ·JBIO has the smaller float (50.2M vs 1.91B), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·JBIO trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·JBIO draws far more of our scanner's attention, 80 unusual-volume alerts in 30 days against 24, so it is the more actively traded of the two by some distance.
- ·They are not really peers by size: NVS is more than 324x the market cap of JBIO, so the same dollar of news moves JBIO far harder.
- ·NVS pays a dividend and JBIO does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing JBIO and NVS on TheDesperateTrader.
- Is JBIO or NVS the better stock?
- "Better" depends on your goal, and these two are not alike. NVS is the larger company by market cap ($291.20B vs $900M). JBIO has been more active on our scanner (80 vs 24 alerts in 30 days). JBIO has the smaller float (50.2M vs 1.91B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between JBIO and NVS?
- The differences that matter: NVS is roughly 324x the size of the other by market cap ($900M vs $291.20B); they trade at very different share prices ($14.51 vs $143.20); JBIO sits at 31% of its 52-week range against 44% for NVS; only NVS pays a dividend; our scanner flagged JBIO 80 times in the last 30 days against 24 for NVS. Everything above is measured from the latest completed session and SEC filings.
- Which of JBIO and NVS is more active right now?
- Right now JBIO is at about 1.9x its normal volume and NVS is at about 0.7x, so JBIO is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading JBIO or NVS? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.